Literature DB >> 21795355

Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells.

Khaled R Alkharsah1, Vivek Vikram Singh, Raffaella Bosco, Susann Santag, Adam Grundhoff, Andreas Konrad, Michael Stürzl, Dagmar Wirth, Oliver Dittrich-Breiholz, Michael Kracht, Thomas F Schulz.   

Abstract

Kaposi's sarcoma herpesvirus (KSHV) Fas-associated death domain (FADD)-like interleukin-1 beta-converting enzyme (FLICE)-inhibitory protein, vFLIP, has antiapoptotic properties, is a potent activator of the NF-κB pathway, and induces the formation of endothelial spindle cells, the hallmark of Kaposi's sarcoma, when overexpressed in primary endothelial cells. We used a reverse genetics approach to study several functions of KSHV vFLIP in the context of the whole viral genome. Deletion of the gene encoding vFLIP from a KSHV genome cloned in a bacterial artificial chromosome (BAC) reduced the ability of the virus to persist and induce spindle cell formation in primary human umbilical vein endothelial cells (HUVECs). Only a few, mainly interferon (IFN)-responsive, genes were expressed in wild-type KSHV (KSHV-wt)-infected endothelial cells at levels higher than those in KSHV-ΔFLIP-infected endothelial cells, in contrast to the plethora of cellular genes induced by overexpressed vFLIP. In keeping with this observation, vFLIP induces the phosphorylation of STAT1 and STAT2 in an NF-κB-dependent manner in endothelial cells. vFLIP-dependent phosphorylation of STAT1 and STAT2 could be demonstrated after endothelial cells were infected with KSHV-wt, KSHV-ΔFLIP, and a KSHV-vFLIP revertant virus. These findings document the impact of KSHV vFLIP on the transcriptome of primary endothelial cells during viral persistence and highlight the role of vFLIP in the activation of STAT1/STAT2 and STAT-responsive cellular genes by KSHV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795355      PMCID: PMC3196410          DOI: 10.1128/JVI.00226-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB.

Authors:  Megan C King; Graça Raposo; Mark A Lemmon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.

Authors:  Shou-Jiang Gao; Jian-Hong Deng; Fu-Chun Zhou
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Authors:  Yiyiang Xu; Don Ganem
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

4.  Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?

Authors:  F Samaniego; S Pati; J E Karp; O Prakash; D Bose
Journal:  J Natl Cancer Inst Monogr       Date:  2001

5.  Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells.

Authors:  Vasu Punj; Hittu Matta; Sandra Schamus; Preet M Chaudhary
Journal:  BMC Med Genomics       Date:  2009-08-06       Impact factor: 3.063

Review 6.  The flip side of FLIP.

Authors:  Marcus E Peter
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

7.  The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.

Authors:  Qinmiao Sun; Sunny Zachariah; Preet M Chaudhary
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

8.  Inhibition of a large double-stranded DNA virus by MxA protein.

Authors:  Christopher L Netherton; Jennifer Simpson; Otto Haller; Thomas E Wileman; Haru-Hisa Takamatsu; Paul Monaghan; Geraldine Taylor
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

9.  STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells.

Authors:  James E McLaren; Jianmin Zuo; Julia Grimstead; Zara Poghosyan; Andrew I Bell; Martin Rowe; Paul Brennan
Journal:  J Gen Virol       Date:  2009-05-13       Impact factor: 3.891

10.  KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.

Authors:  Victoria Emuss; Dimitrios Lagos; Arnold Pizzey; Fiona Gratrix; Stephen R Henderson; Chris Boshoff
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more
  27 in total

1.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

3.  Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.

Authors:  Bizunesh Abere; Naira Samarina; Silvia Gramolelli; Jessica Rückert; Gisa Gerold; Andreas Pich; Thomas F Schulz
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65.

Authors:  Anika Hävemeier; Silvia Gramolelli; Marcel Pietrek; Ramona Jochmann; Michael Stürzl; Thomas F Schulz
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

5.  NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process.

Authors:  Bhairavi Tolani; Hittu Matta; Ramakrishnan Gopalakrishnan; Vasu Punj; Preet M Chaudhary
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.

Authors:  Tatyana Dubich; Anna Lieske; Susann Santag; Guillaume Beauclair; Jessica Rückert; Jennifer Herrmann; Jan Gorges; Guntram Büsche; Uli Kazmaier; Hansjörg Hauser; Marc Stadler; Thomas F Schulz; Dagmar Wirth
Journal:  J Mol Med (Berl)       Date:  2019-01-04       Impact factor: 4.599

7.  Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.

Authors:  Fang Lu; Kevin Tsai; Horng-Shen Chen; Priyankara Wikramasinghe; Ramana V Davuluri; Louise Showe; John Domsic; Ronen Marmorstein; Paul M Lieberman
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.

Authors:  Vivek Vikram Singh; Nagaraj Kerur; Virginie Bottero; Sujoy Dutta; Sayan Chakraborty; Mairaj Ahmed Ansari; Nitika Paudel; Leela Chikoti; Bala Chandran
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

9.  Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Authors:  Kimberley D Gutierrez; Valerie A Morris; David Wu; Serge Barcy; Michael Lagunoff
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

10.  Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells.

Authors:  Barbara Ruder; Vinay Murtadak; Michael Stürzl; Stefan Wirtz; Ute Distler; Stefan Tenzer; Mousumi Mahapatro; Florian R Greten; Yinling Hu; Markus F Neurath; Ethel Cesarman; Gianna Ballon; Claudia Günther; Christoph Becker
Journal:  Mucosal Immunol       Date:  2018-08-13       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.